Apotea

APOTEA · Nasdaq Stockholm · Healthcare

82.05SEK −1.3%last day

Price as of 2 October 2026

The price over the past year, with dividends: −7.7%

Performance

1 month

+5.0%

1 year

−7.7%

3 years, per year

–

5 years, per year

–

Largest fall, 3 years

−54.1%

Below the peak now

−31.7%

Volatility, 1 year

40.0%

Return with dividends reinvested.

Key figures

P/E

33.6

P/B

8.7

Dividend yield

0.7%

Return on equity

+25.9%

Net margin

+3.2%

Market value

850 m USD

Quality, value and trend

Where Apotea stands against every Nordic stock today. 100 is best.

Quality57

Profitability and a sound balance sheet over time. Better than 57% of Nordic stocks.

Value33

The price measured against earnings, assets and cash flow. Better than 33% of Nordic stocks.

Trend69

The price development over the past year. Better than 69% of Nordic stocks.

Combined51

Quality, value and trend together. Better than 51% of Nordic stocks.

About Apotea

Apotea is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 740 employees.

Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, charity, and eyes and ears.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis